Development of FERM domain protein-protein interaction inhibitors for MSN and CD44 as a potential therapeutic strategy for Alzheimer's disease. https://www.biorxiv.org/content/10.1101/2023.05.22.541727v1?med=mas
Development of FERM domain protein-protein interaction inhibitors for MSN and CD44 as a potential therapeutic strategy for Alzheimer's disease. https://www.biorxiv.org/content/10.1101/2023.05.22.541727v1?med=mas